2/24/26, 9:19 PM Pharm Final 100 Questions
Pharmacology Actual Test Bank Exam
2026-2027\Complete questions &
Accurate Detailed Answers
1. A nurse is monitoring a client who is receiving Epoetin alfa for adverse effects. The
nurse should identify which of the following findings as an adverse effect of this
medication?
a. Edema and hematuria
b. Blurred vision and edema
c. Urinary retention and abdominal pain
d. Hypertension and headache
D.
Hypertension and headache.
1/80
,2/24/26, 9:19 PM Pharm Final 100 Questions
2. A patient with Parkinson's disease is taking levodopa/carbidopa [Sinemet] and reports
occasional periods of loss of drug effect lasting from minutes to several hours. The nurse
questions the patient further and discovers that these episodes occur at different times
related to the medication administration. The nurse will contact the provider to discuss:
a. administering a catechol-O-methyltransferase (COMT) inhibitor, such as entacapone.
b. adding the DA-releasing agent amantadine to the regimen.
c. giving a direct-acting dopamine agonist.
d. shortening the dosing interval of levodopa/carbidopa.
A
This patient is describing abrupt loss of effect, or the "off" phenomenon, which is treated
with
entacapone or another COMT inhibitor. Amantadine is used to treat dyskinesias. A direct-
acting dopamine agonist is useful for gradual loss of effect, which occurs at the end of the
dosing interval as the dose is wearing off. Shortening the dosing interval does not help with
abrupt loss of effect.
2/80
,2/24/26, 9:19 PM Pharm Final 100 Questions
3. A patient with atrial fibrillation is receiving warfarin [Coumadin]. The nurse notes that the
patient's INR is 2.7. Before giving the next dose of warfarin, the nurse will notify the
provider and:
a. administer the dose as ordered.
b. request an order to decrease the dose.
c. request an order to give vitamin K (phytonadione).
d. request an order to increase the dose.
A
This patient has an INR in the appropriate range, which is 2 to 3 for most patients and 2.5 to
3.5 for some, so no change in warfarin dosing is necessary. It is not correct to request an
order
to either decrease or increase the dose of warfarin. It is not necessary to give vitamin K,
which is an antidote for warfarin toxicity.
3/80
, 2/24/26, 9:19 PM Pharm Final 100 Questions
4. A 65-year-old patient who receives glucocorticoids for arthritis is admitted to the
hospital for treatment of a urinary tract infection. The prescriber has ordered intravenous
ciprofloxacin [Cipro]. Before administering the third dose of this drug, the nurse reviews the
bacterial culture report and notes that the causative organism is Escherichia coli. The
bacterial sensitivity report is pending. The patient complains of right ankle pain. What will
the nurse do?
a. Withhold the dose of ciprofloxacin and notify the provider of the patient's
symptoms.
b. Instruct the patient to exercise the right foot and ankle to minimize the pain.
c. Question the patient about the consumption of milk and any other dairy products.
d. Request an order to increase this patient's dose of glucocorticoids.
A
A rare but serious adverse effect associated with fluoroquinolones is tendon rupture, and
those
at highest risk are children, patients older than 60 years, transplant patients, and any
patients
taking glucocorticoids. Any pain in either heel should be reported and the drug should be
discontinued. Patients should be instructed not to exercise until tendonitis has been ruled
out.
Dairy products can reduce the absorption of ciprofloxacin, so this is not a concern with this
patient. Because the pain may be caused by tendonitis associated with ciprofloxacin, it is not
correct to request an increase in the glucocorticoid dosing.
4/80
Pharmacology Actual Test Bank Exam
2026-2027\Complete questions &
Accurate Detailed Answers
1. A nurse is monitoring a client who is receiving Epoetin alfa for adverse effects. The
nurse should identify which of the following findings as an adverse effect of this
medication?
a. Edema and hematuria
b. Blurred vision and edema
c. Urinary retention and abdominal pain
d. Hypertension and headache
D.
Hypertension and headache.
1/80
,2/24/26, 9:19 PM Pharm Final 100 Questions
2. A patient with Parkinson's disease is taking levodopa/carbidopa [Sinemet] and reports
occasional periods of loss of drug effect lasting from minutes to several hours. The nurse
questions the patient further and discovers that these episodes occur at different times
related to the medication administration. The nurse will contact the provider to discuss:
a. administering a catechol-O-methyltransferase (COMT) inhibitor, such as entacapone.
b. adding the DA-releasing agent amantadine to the regimen.
c. giving a direct-acting dopamine agonist.
d. shortening the dosing interval of levodopa/carbidopa.
A
This patient is describing abrupt loss of effect, or the "off" phenomenon, which is treated
with
entacapone or another COMT inhibitor. Amantadine is used to treat dyskinesias. A direct-
acting dopamine agonist is useful for gradual loss of effect, which occurs at the end of the
dosing interval as the dose is wearing off. Shortening the dosing interval does not help with
abrupt loss of effect.
2/80
,2/24/26, 9:19 PM Pharm Final 100 Questions
3. A patient with atrial fibrillation is receiving warfarin [Coumadin]. The nurse notes that the
patient's INR is 2.7. Before giving the next dose of warfarin, the nurse will notify the
provider and:
a. administer the dose as ordered.
b. request an order to decrease the dose.
c. request an order to give vitamin K (phytonadione).
d. request an order to increase the dose.
A
This patient has an INR in the appropriate range, which is 2 to 3 for most patients and 2.5 to
3.5 for some, so no change in warfarin dosing is necessary. It is not correct to request an
order
to either decrease or increase the dose of warfarin. It is not necessary to give vitamin K,
which is an antidote for warfarin toxicity.
3/80
, 2/24/26, 9:19 PM Pharm Final 100 Questions
4. A 65-year-old patient who receives glucocorticoids for arthritis is admitted to the
hospital for treatment of a urinary tract infection. The prescriber has ordered intravenous
ciprofloxacin [Cipro]. Before administering the third dose of this drug, the nurse reviews the
bacterial culture report and notes that the causative organism is Escherichia coli. The
bacterial sensitivity report is pending. The patient complains of right ankle pain. What will
the nurse do?
a. Withhold the dose of ciprofloxacin and notify the provider of the patient's
symptoms.
b. Instruct the patient to exercise the right foot and ankle to minimize the pain.
c. Question the patient about the consumption of milk and any other dairy products.
d. Request an order to increase this patient's dose of glucocorticoids.
A
A rare but serious adverse effect associated with fluoroquinolones is tendon rupture, and
those
at highest risk are children, patients older than 60 years, transplant patients, and any
patients
taking glucocorticoids. Any pain in either heel should be reported and the drug should be
discontinued. Patients should be instructed not to exercise until tendonitis has been ruled
out.
Dairy products can reduce the absorption of ciprofloxacin, so this is not a concern with this
patient. Because the pain may be caused by tendonitis associated with ciprofloxacin, it is not
correct to request an increase in the glucocorticoid dosing.
4/80
